Literature DB >> 6818591

Prostaglandin inhibition of amphetamine-induced circling in mice.

R D Schwarz, N J Uretsky, J R Bianchine.   

Abstract

The effect of prostaglandins (PG) on amphetamine(AMPH)-induced circling was examined in mice unilaterally lesioned with 6-hydroxy-dopamine. At doses of 0.03-1.0 nmol/g, intraventricularly injected PGD2, PGE2, and PGF2 alpha all inhibited AMP-induced circling, while thromboxane-B2 (TxB2) was inactive at 1.0 nmol/g. The inhibition of circling was not due to alterations in body temperature as measured by rectal temperature changes. When injected intrastriatally, the same major PG inhibited AMP-induced circling at the lower doses of 0.01-0.1 nmol/g, while the PGE2 metabolite 13, 14-dihydro-15-keto-PGE2 was inactive at 0.1 nmol/g. PG administered alone did not procude circling. For both routes of administration, the order of potency was PGE2 greater than PGD2 greater than PGF2 alpha. These results suggest that PG can alter motor function governed by central dopaminergic pathways.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818591     DOI: 10.1007/bf00433733

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  IDENTIFICATION OF A SMOOTH MUSCLE-STIMULATING FACTOR IN BOVINE BRAIN. PROSTAGLANDINS AND RELATED FACTORS 25.

Authors:  B SAMUELSSON
Journal:  Biochim Biophys Acta       Date:  1964-04-20

Review 2.  Basic mechanisms of prostaglandin action on autonomic neurotransmission.

Authors:  P Hedqvist
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  Effects of prostaglandin E 2 on the body temperature of conscious rats and cats.

Authors:  W J Potts; P F East
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-05

4.  Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  Effect of prostaglandin E 2 on central and peripheral catecholamine neurons.

Authors:  S Bergström; L O Farnebo; K Fuxe
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

7.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

8.  Effect of prostaglandins D2, E2 and F2alpha on catecholamine release from slices of rat and rabbit brain.

Authors:  W Reimann; H B Steinhauer; L Hedler; K Starke; G Hertting
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

9.  ACTIONS OF PROSTAGLANDINS E1, E2 AND E3 ON THE CENTRAL NERVOUS SYSTEM.

Authors:  E W HORTON
Journal:  Br J Pharmacol Chemother       Date:  1964-02

10.  Regional and species differences in endogenous prostaglandin biosynthesis by brain homogenates.

Authors:  M S Abdel-Halim; E Anggård
Journal:  Prostaglandins       Date:  1979-03
View more
  2 in total

1.  Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions.

Authors:  R S Kahn; M Davidson; P Kanof; R T McQueeney; R R Singh; K L Davis
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent.

Authors:  B Costall; M E Kelly; R J Naylor
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.